EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial

Eva Gravdahl iD, Ola Dale, Jūratė Šaltytė Benth, Siri Steine, Knut Magne Augestad, Olav Magnus Fredheim

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70191 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Eva Gravdahl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Morphine, Analgesics, Opioid, Palliative Care, Neoplasms. Die Arbeit nennt 23 Literaturangaben. Gefördert von: South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF), Helse Sør-Øst RHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To compare the pharmacokinetics of intravenous (IV) and subcutaneous (SC) morphine bolus doses in palliative care patients receiving patient‐controlled analgesia.

Methods

This pharmacokinetic substudy of a double‐blinded, randomized controlled trial included 20 patients with advanced cancer requiring morphine infusion. After 20–48 h of patient‐controlled analgesia, a baseline blood sample was drawn before bolus administration, followed by 16 samples over 2 h. Time to maximum concentration, maximum concentration and area under the curve to 60 min (AUC0–60) were determined. Group differences were assessed using linear mixed‐effects modelling.

Results

Median (Q1, Q3) time to maximum concentration was significantly shorter for IV (2 [2, 2] min) compared to SC (10 [5, 15] min, P < .001). Dose‐adjusted maximum concentration was 3 times higher in the IV group. Linear mixed‐effects modelling showed on average, significantly higher serum concentrations for IV during the 0–60 min period postbolus, although differences in AUC0–60 were not statistically significant (mean AUC0–60: SC, 7621 nmol min/L [95% confidence interval: 5714–10 163]; IV, 9382 nmol min/L [95% confidence interval: 5914–14 884]). At steady state, higher infusion rates were associated with markedly higher concentrations in the IV group. Low albumin correlated with higher serum morphine concentrations. No differences in respiratory rates or sedation were observed.

Conclusions

IV morphine showed faster absorption with substantially higher peak concentrations compared to SC. Further research is needed to assess the clinical relevance of these differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphineAnalgesics, OpioidPalliative CareNeoplasmsCancer PainHumansMaleFemaleMiddle AgedDouble-Blind MethodAgedAnalgesia, Patient-ControlledInfusions, IntravenousInjections, SubcutaneousArea Under CurveAdultInfusions, SubcutaneousAged, 80 and over

Stichwörter der Autor:innen

absorptioncanceropioidspalliative care

Substanzen

MorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Palliative Medicine, Akershus University Hospital, Lørenskog, Norway.
  • Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU: Norwegian University of Science and Technology, Trondheim, Norway.
  • Institute of Clinical Medicine, Campus Ahus, University of Oslo, Blindern, Norway.
  • Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway.
  • Department of Gastrointestinal Surgery, Akershus University Hospital, Oslo, Norway.

ORCID-Profile: Eva Gravdahl

Förderung

  • South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF)
  • Helse Sør-Øst RHF

Zitieren

APA

Gravdahl, E., Dale, O., Benth, J. Š., Steine, S., Augestad, K. M., & Fredheim, O. M. (2025). Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70191

Vancouver

Gravdahl E, Dale O, Benth JŠ, Steine S, Augestad KM, Fredheim OM. Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70191

BibTeX
@article{Gravdahl2025,
  author = {Gravdahl, Eva and Dale, Ola and Benth, Jūratė Šaltytė and Steine, Siri and Augestad, Knut Magne and Fredheim, Olav Magnus},
  title = {Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70191}
}
Kostenlos starten →